GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we approach type 2 diabetes . These injectable therapies function to imitating the body’s own GLP-1 substance https://minibookmarking.com/story21866311/glp-1-a-revolutionary-approach-in-blood-sugar-care